account_id none on file
legal_name Milestone Pharmaceuticals Inc.
ticker MIST
cik 1408443
domain milestonepharma.com
linkedin_company_url https://www.linkedin.com/company/5882207
entry_point_account_id none on file
exchange Nasdaq
sector Health Care
hq Montreal, Quebec, Canada
sector index/company/sector/health-care/
calls 0 filings 2 executives 1 family 0
why_nownone on file
callsnone on file
filings
Failure to generate sufficient cash flows from operations, raise additional capital and reduce discretionary spending should additional capital not become available could have a material adverse effect on the Company’s ability to achieve its business objectives.
filing / Aug 12, 2026 / receipt
Failure to generate sufficient cash flows from operations, raise additional capital and reduce discretionary spending should additional capital not become available could have a material adverse effect on the Company’s ability to achieve its business objectives.
filing / May 13, 2026 / receipt
executives
| Amit Hasija | Chief Financial Officer and Executive Vice President of Corporate Development | receipt |
familynone on file
upcoming
changes
| 2019-09-10 | Chief Financial Officer, appointed | sec_8k |
mcp_package_hint
slug milestone-pharmaceuticals-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$